
Overview
Sanford Biotech is a company that develops stem cell therapies and growth factor treatments for both human and veterinary medicine. It offers advanced biological therapies for companion animals, including innovative treatments for arthritis in dogs and atopic dermatitis in dogs and cats. Additionally, it focuses on therapies for horses and dairy cattle, reflecting a shift in how these animals are perceived and treated in veterinary care.
Financials
Revenue history
From the notes
| Profit allocation | No decision | |
| Capital expenditure | $42,307 | |
| Planned capital expenditure (next year) | $25,113 | |
| Related parties | 1 items |
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 130 days for 2021).
- 202514/07/2026
- 202410/07/2025
- 202318/07/2024
- 202218/07/2023
- 202122/11/2022
- 202018/11/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Stem cell therapies
- Platelet-rich plasma therapy
- Biological therapies
- Translational research
Websites
- sanfordbiotech.comSanford Biotech | komórki macierzyste i badania translacyjneGoogle AnalyticsGoogle Tag ManagerLLiteSpeed
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 154 | $2,079.96 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2025-08-01.
54 1050 1025 1000 0090 8021 6162
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biotransplant Research sp. z o.o. | $22,953.29 | biotransplant.pl | ||
| Polfarmex Biotechnologie sp. z o.o. | $3,013.56 | polfarmex.pl | ||
| Instytut Rolnictwa Ekologicznego Ireko sp. z o.o. | $1,542.08 | revolorganic.pl | ||
| BNF - New Bio Force sp. z o.o. | $284.03 | bnf.edu.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-17 | Share capital increase (5,000.00 PLN → 7,700.00 PLN) | |
| 2025-09-17 | Switch to PKD 2025 (1 PKD 2007 code → 9 PKD 2025 codes) | |
| 2017-07-20 | Entered in the register |
FAQ
Last updated: 2026-10-07